PYXS short interest
Pyxis Oncology Inc. · Healthcare · Biotechnology · settlement date 2026-09-30
| Shares short | 4,886,652 |
|---|---|
| Change vs prior report | 208,130 (+4.5%) |
| Change over six months | +83.6% |
| Days to cover | 4.05 (sector: 3.78) |
| Average daily volume | 1,207,832 |
| Rank in Healthcare | #521 of 922 by days to cover |
PYXS short interest, last 12 months
| Settlement | Shares short | Change | Days to cover | Avg daily volume |
|---|---|---|---|---|
| 2026-09-30 | 4,886,652 | +4.5% | 4.05 | 1,207,832 |
| 2026-09-15 | 4,678,522 | +17.9% | 3.65 | 1,282,071 |
| 2026-08-31 | 3,968,105 | -10.3% | 6.96 | 569,963 |
| 2026-08-14 | 4,425,542 | +6.1% | 1.99 | 2,219,479 |
| 2026-07-31 | 4,172,154 | +28.2% | 4.19 | 996,532 |
| 2026-07-15 | 3,253,653 | +42.1% | 3.11 | 1,045,845 |
| 2026-06-30 | 2,289,798 | +13.6% | 1.25 | 1,838,587 |
| 2026-06-15 | 2,015,710 | +15.7% | 4.85 | 415,478 |
| 2026-05-29 | 1,741,743 | -3.8% | 2.87 | 607,711 |
| 2026-05-15 | 1,809,793 | -8.9% | 2.11 | 855,956 |
| 2026-04-30 | 1,986,201 | -12.5% | 5.51 | 360,768 |
| 2026-04-15 | 2,269,065 | -14.7% | 5.64 | 402,636 |
| 2026-03-31 | 2,660,931 | +6.8% | 7.37 | 360,879 |
| 2026-03-13 | 2,490,249 | -1.4% | 7.70 | 323,380 |
| 2026-02-27 | 2,525,155 | +3.4% | 9.85 | 256,287 |
| 2026-02-13 | 2,442,905 | +2.4% | 3.78 | 645,837 |
| 2026-01-30 | 2,386,094 | +3.4% | 3.94 | 605,707 |
| 2026-01-15 | 2,307,831 | +33.1% | 1.20 | 1,930,381 |
| 2025-12-31 | 1,733,403 | -10.3% | 1.00 | 2,886,868 |
| 2025-12-15 | 1,933,041 | -57.3% | 3.00 | 645,262 |
| 2025-11-28 | 4,523,744 | -0.4% | 7.66 | 590,643 |
| 2025-11-14 | 4,541,093 | +4.1% | 4.79 | 947,872 |
| 2025-10-31 | 4,361,521 | +2.6% | 7.79 | 559,670 |
| 2025-10-15 | 4,250,799 | +2.9% | 3.91 | 1,088,009 |
| 2025-09-30 | 4,131,340 | -5.2% | 6.02 | 686,661 |
import finzdata as yf
yf.Ticker("PYXS").short_interest # every report since 2017
yf.Client().short_interest(["PYXS"], start="2018-01-01")Healthcare short interest · PYXS price history · Who owns PYXS · All short interest